Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors
- PMID: 2820344
Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors
Abstract
Synaptophysin, a membrane glycoprotein of presynaptic vesicles, and neurofilament (NF) proteins were tested as immunohistochemical markers for neuroendocrine tumors. Synaptophysin was consistently present in the tumor cells of pheochromocytomas (10/10), thyroid medullary carcinomas (8/8), and pancreatic islet cell tumors (6/6). Most gastrointestinal and thoracic carcinoid tumors (12/13) were positive, as were neuroendocrine carcinomas (7/9), of which two Merkel cell carcinomas were negative. The NF proteins were present in all pheochromocytomas, in three thoracic and one gastric carcinoid tumors, in four of eight thyroid medullary carcinomas, and in five of six pancreatic islet cell tumors. All intestinal carcinoids were negative for NF proteins, as were neuroendocrine carcinomas, except for two Merkel cell carcinomas that were positive. The 68-kilodalton (kd) NF subunit protein was the most prevalent in all NF-positive neuroendocrine tumors, and the 160-kd subunit was relatively often present, although in a smaller number of cells. The 200-kd NF subunit protein was regularly found in pheochromocytomas and only occasionally found in other neuroendocrine tumors. A series of nonneuroendocrine tumors, such as adenocarcinomas, sarcomas, lymphomas, and melanomas, were negative for both synaptophysin and NF proteins. Thus, synaptophysin is a specific and fairly sensitive marker for neuroendocrine tumors of both low and high grades of malignancy. The NF proteins are good markers for pheochromocytoma, and their presence is of basic tumor biologic interest and of potential diagnostic value in other neuroendocrine neoplasms.
Similar articles
-
Expression of intermediate filaments in neuroendocrine tumors.Arch Pathol Lab Med. 1990 May;114(5):506-10. Arch Pathol Lab Med. 1990. PMID: 2159272
-
Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry.Am J Pathol. 1987 Feb;126(2):243-57. Am J Pathol. 1987. PMID: 3103452 Free PMC article.
-
Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.Acta Histochem Suppl. 1990;38:179-81. Acta Histochem Suppl. 1990. PMID: 1964227
-
Pathology of adrenal neoplasms.Minerva Endocrinol. 1995 Mar;20(1):1-8. Minerva Endocrinol. 1995. PMID: 7651277 Review.
-
Ultrastructural and functional relationships of some human endocrine tumors.Pathol Annu. 1973;8:205-30. Pathol Annu. 1973. PMID: 4364440 Review. No abstract available.
Cited by
-
Coexpression of cytokeratin, neurofilament and vimentin in carcinoid tumors.Virchows Arch A Pathol Anat Histopathol. 1989;415(1):69-77. doi: 10.1007/BF00718606. Virchows Arch A Pathol Anat Histopathol. 1989. PMID: 2472033
-
Primary neuroendocrine carcinoma of the thymus.Niger Med J. 2013 Jan;54(1):68-71. doi: 10.4103/0300-1652.108904. Niger Med J. 2013. PMID: 23661903 Free PMC article.
-
Endocrine neoplasms of the pancreas: a clinicopathologic study of 24 cases and immunohistochemical remarks.Surg Today. 1992;22(4):305-12. doi: 10.1007/BF00308737. Surg Today. 1992. PMID: 1392340
-
Various Markers of Neuroendocrine Tumor: A Narrative Review.Cureus. 2024 Aug 22;16(8):e67493. doi: 10.7759/cureus.67493. eCollection 2024 Aug. Cureus. 2024. PMID: 39314560 Free PMC article. Review.
-
An immunohistochemical study of the primitive and maturing elements of human cerebral medulloepitheliomas.Acta Neuropathol. 1989;79(3):248-54. doi: 10.1007/BF00294658. Acta Neuropathol. 1989. PMID: 2609935